Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name ...

These four S&P 500 stocks pay 6% and higher dividends, have Buy ratings at top Wall Street firms, and are offering excellent ...

As with Ibrance, availability for previously-treated patients was via the CDF while additional evidence of efficacy is gathered. Kisqali and Verzenios moved to routine funding last year. Keytruda ...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025. Cybertruck blast driver identified; link to New Orleans attacker growing ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...